AMRX Total Non-Current Liabilities
Amneal Pharmaceuticals Inc Class A · Total Non-Current Liabilities
AMRX Total Non-Current Liabilities
Latest reported$2.78Bperiod ending
AMRX Quarterly Total Non-Current Liabilities ($1.16B → $2.78B)
Quarterly total non-current liabilities
High-resolution chart · PNG
AMRX total non-current liabilities history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Total Non-Current Liabilities (USD) |
|---|---|
| 2,776,181,000 | |
| 2,858,138,000 | |
| 2,790,684,000 | |
| 2,847,723,000 | |
| 2,362,385,000 | |
| 2,348,814,000 | |
| 2,416,212,000 | |
| 2,399,449,000 | |
| 2,399,636,000 | |
| 2,638,616,000 | |
| 2,564,670,000 | |
| 2,735,098,000 | |
| 2,740,662,000 | |
| 2,760,701,000 | |
| 2,837,613,000 | |
| 2,839,380,000 | |
| 2,857,465,000 | |
| 2,863,098,000 | |
| 2,878,541,000 | |
| 2,908,648,000 | |
| 2,945,807,000 | |
| 2,956,583,000 | |
| 2,972,395,001 | |
| 3,021,454,000 | |
| 3,030,721,000 | |
| 3,022,277,000 | |
| 2,768,696,000 | |
| 2,773,309,000 | |
| 2,966,628,000 | |
| 2,985,275,000 | |
| 2,902,523,000 | |
| 2,917,458,000 | |
| 2,935,366,000 | |
| 1,392,187,000 | |
| 1,420,588,000 | |
| 1,398,198,000 | |
| 0 | |
| 1,159,566,000 |